Skip to main content

Published locations for FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients

User login

  • Reset your password
  • /content/fda-approves-rivaroxaban-vte-prevention-hospitalized-acutely-ill-patients
  • /clinicianreviews/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /familypracticenews/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /hematologynews/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /internalmedicinenews/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /hospitalist/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized-acutely
  • /vascularspecialistonline/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention
  • /jcomjournal/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized-acutely
  • /hematology-oncology/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /hematologytimes/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /ecardiologynews/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /cardiology/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized-acutely
  • /internalmedicine/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /familymedicine/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized
  • /chestphysician/article/210145/thrombosis/fda-approves-rivaroxaban-vte-prevention-hospitalized